A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease

NCT04609397 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

89

Enrollment

INDUSTRY

Sponsor class

Stopped The study purpose has been achieved

Conditions

Behçet Disease

Interventions

DRUG: Hemay005
DRUG: Hemay005
OTHER: Placebo

Sponsor

Tianjin Hemay Pharmaceutical Co., Ltd